BOSTON, Aug. 8, 2018 /PRNewswire/ -- Decision Resources Group (DRG), a premier provider of healthcare data, analytics, and insights products and services, announced Davis Walp has joined as Chief Strategy Officer.

Decision Resources Group Logo. (PRNewsFoto/Decision Resources Group)

In his new role, Walp will focus his efforts on growth strategies that will drive new value for DRG's customers. He brings more than 20 years of global strategy and operations experience across pharmaceutical, health technology and provider segments.

"As the healthcare industry undergoes transformative changes, Davis will help DRG bring the next generation of customer-driven solutions to the industry," said Jon Sandler, Chief Executive Officer at Decision Resources Group. "His understanding of the complexity of the healthcare system will strengthen DRG's role as a trusted partner, helping our customers anticipate industry changes and stay competitive in a fast-moving market."

Prior to DRG, Walp headed strategy and business development for Allscripts' genomics and precision medicine venture, and was Market Segment Leader for Allscripts' research offerings to life sciences sponsors. Walp's background in healthcare data and technology includes real world evidence analytics and patient engagement at internal startups within Deloitte and Quintiles (now IQVIA). He also brings to DRG over a decade of experience at leading pharmaceutical companies including Johnson & Johnson, Pfizer, and GlaxoSmithKline in roles spanning from brand planning to corporate strategy.

"Healthcare is evolving quickly, and DRG is a company with a strong legacy of making the complex clear and compelling for decision makers through data, insights and recommendations," said Davis Walp, Chief Strategy Officer at Decision Resources Group. "I'm looking forward to elevating DRG's position as a trusted partner, by helping our customers successfully navigate rapid change across science, healthcare delivery, payment and regulatory models."

About Decision Resources Group

DRG, a subsidiary of Piramal Enterprises Ltd., is the premier source for global healthcare data and market intelligence. A trusted partner for over 20 years, DRG helps companies competing in the global healthcare industry make informed business decisions. Organizations committed to developing and delivering life-changing therapies to patients rely on DRG's in-house team of expert healthcare analysts, data scientists, and consultants for critical guidance. DRG products and services, built on extensive data assets and delivered by experts, empower organizations to succeed in complex healthcare markets.

To learn more, visit

Media contact:
Kate Hahn:

Related Links

SOURCE Decision Resources Group

Pharma reps and websites carry clout with physicians in Japan

View Now